Journals / Turkish Journal of Surgery / 2018 / Cilt: 34 - Sayı: 2

Where do these guests come from? A diagnostic approach for metastatic lymph nodes

Pages
131–136
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The histopathological evaluation of the excisional metastatic lymph node biopsies is an importantmethod because of cost effectiveness and easy applicability.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: In cases presenting with lymphadenopathies (LAP) without a primary focus detected by simple radiologicalmethods, the primary tumor can be diagnosed by a histopathological evaluation of the metastatic lymph nodes.We aimed to discuss the nonhematological malignancies presenting with lymphadenopathies and the histopathologicalresults for primary tumors.Material and Methods: In this retrospective study, cases diagnosed with metastasis in excisional lymph nodes betweenJanuary 2013 and June 2016 were assessed for a histopathological diagnostic approachResults: Among 632 lymph node biopsies, a total of 21 cases, involving 12 male and 9 female patients with amean age of 57.23 y (range, 33–92 y), of nonhematological solid tumors were included.
📊
Key Findings & Data:The most common localizationsof the involved lymph nodes were inguinal (n=8), axillary (n=6), cervical (n=4), and supraclavicular(n=3) region.
💡
Conclusion & Impact:The histopathological evaluation of the excisional metastatic lymph node biopsies is an importantmethod because of cost effectiveness and easy applicability.
🔬Design:Research Article
📍Scope:2013 Verileri
⚙️Variables:Domain Parameters

Özet

Objective: In cases presenting with lymphadenopathies (LAP) without a primary focus detected by simple radiologicalmethods, the primary tumor can be diagnosed by a histopathological evaluation of the metastatic lymph nodes.We aimed to discuss the nonhematological malignancies presenting with lymphadenopathies and the histopathologicalresults for primary tumors.Material and Methods: In this retrospective study, cases diagnosed with metastasis in excisional lymph nodes betweenJanuary 2013 and June 2016 were assessed for a histopathological diagnostic approachResults: Among 632 lymph node biopsies, a total of 21 cases, involving 12 male and 9 female patients with amean age of 57.23 y (range, 33–92 y), of nonhematological solid tumors were included. The most common localizationsof the involved lymph nodes were inguinal (n=8), axillary (n=6), cervical (n=4), and supraclavicular(n=3) region. The most common primary tumors were malignant melanoma (n=6), breast carcinoma (n=4),ovarian carcinoma (n=2), squamous cell carcinoma (n=2), and germ cell tumor (n=2). Others were papillarythyroid carcinoma, renal cell carcinoma, urothelial carcinoma, prostate adenocarcinoma, and endometrialadenocarcinoma.Conclusion: Nonhematological malignancies presenting with lymphadenopathies are one of the most complicatedcases for clinicians. The histopathological evaluation of the excisional metastatic lymph node biopsies is an importantmethod because of cost effectiveness and easy applicability.

🔖

Cite This Article

DERE, Y., EKMEKÇİ, S., ÇELİK, S. Y., ÇELİK, Ö. İ., DERE, Ö., KARAKUŞ, V. (2018). Where do these guests come from? A diagnostic approach for metastatic lymph nodes. Turkish Journal of Surgery, Cilt: 34 - Sayı: 2, 131–136. https://ajindex.com/articles/390570

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (3)

  1. Krementz ET, Cerise EJ, Foster DS, Morgan LR Jr. Metastases of undetermined source. Curr Probl Cancer 1979; 4: 4-37. [CrossRef] Natoli C, Ramazzotti V, Nappi O, Giacomini P, Palmeri S, Salvatore M et al. Unknown primary tumors: Review. Biochimica et Biophysica Acta 2011; 1816: 13-24. [CrossRef] Abbruzzese JL, Abbruzzese MC, Lenzi R, Hess KR, Raber MN. Analysis of a diagnostic strategy for patients with suspected tumours of unknown primary origin. J Clin Oncol 1995; 13: 2094-103. [CrossRef] Orel SG, Weinstein SP, Schnall MD, Reynolds CA, Schuchter LM, Fraker DL et al. Breast MR imaging in patients with axillary node metastases and unknown primary malignancies. Radiology 1999; 212: 543-549. [CrossRef] Seve P, Billotey C, Broussolle C, Dumontet C, Mackey JR. The role of 2-deoxy-2-[F-18] fluoro-D-glucose positron emission tomography in disseminated carcinoma of unknown primary site. Cancer 2007; 109: 292-299. [CrossRef] Lassen U, Daugaard G, Eigtved A, Damgaard K, Friberg L. 18FFDG whole body positron emission tomography (PET) in patients with unknown primary tumours (UPT). Eur J Cancer 1999;35: 1076-1082. [CrossRef] Rades D, Kuhnel G, Wildfang I, Börner AR, Schmoll HJ, Knapp W.Localised disease in can- cer of unknown primary (CUP): the value of positron emission tomography (PET) for individual therapeutic management. Ann Oncol 2001; 12: 1605-1609. [CrossRef] Kwee TC, Kwee RM. Combined FDG-PET/CT for the detection of unknown primary tumors: systematic review and meta-analysis. Eur Radiol 2009; 19: 731-744. [CrossRef] Şimsek F, Entok E. Primeri Bilinmeyen Kanserlerde Primer Odak Tespitinde PET/BT’nin Etkinliği. Firat Med J 2015; 20: 33-36.
  2. Başal Y, Eryılmaz A. Primeri Bilinmeyen Boyun Metastazlarına Güncel Yaklaşım. Van Tıp Derg 2016; 23: 294-300.
  3. Schapira DV, Jarrett AR. The need to consider survival, outcome, and expense when evaluating and treating patients with unknown primary carcinoma. Arch Intern Med 1995; 155: 2050- 2054. [CrossRef] Mottolese M, Venturo I, Salzano M, Benevolo M, Bigotti A, Natali PG. Immunocytodiagnosis of solid tumors employing panels of monoclonal antibodies. J Clin Lab Anal 1993; 7: 238-242. [CrossRef] Greco FA, Hainsworth JD. Poorlydifferentiatedcarcinoma (with or without features of adenocarcinoma) of unknown primary site. Adenocarcinoma of unknown primary site. In: DeVita VT, Hellman S, Rosenberg SA, editors. Cancer Principles & Practice of Oncology: Cancer of Unknown Primary Site. 7th ed. Philedelphia: Lipincott Williams & Wilkin